Cargando…

Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders

Thyroid hormones (THs) elicit significant effects on numerous physiological processes, such as growth, development, and metabolism. A lack of thyroid hormones is not compatible with normal health. Most THs effects are mediated by two different thyroid hormone receptor (TR) isoforms, namely TRα and T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saponaro, Federica, Sestito, Simona, Runfola, Massimiliano, Rapposelli, Simona, Chiellini, Grazia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363807/ https://www.ncbi.nlm.nih.gov/pubmed/32733906 http://dx.doi.org/10.3389/fmed.2020.00331

Ejemplares similares

Potential role of two novel agonists of thyroid hormone receptor‐β on liver regeneration
por: Perra, Andrea, et al.
Publicado: (2020)

New Multitarget Approaches in the War Against Glioblastoma: A Mini-Perspective
por: Sestito, Simona, et al.
Publicado: (2018)

SUN-717 SG-2 a Novel Multi-Target Directed Ligand (MTDL) for the Treatment of Neurodegenerative Diseases (NDDS)
por: Sestito, Simona, et al.
Publicado: (2020)

Collecting data through high throughput in vitro early toxicity and off-target liability assays to rapidly identify limitations of novel thyromimetics
por: Runfola, Massimiliano, et al.
Publicado: (2020)

Beyond Antioxidant Effects: Nature-Based Templates Unveil New Strategies for Neurodegenerative Diseases
por: Bacci, Andrea, et al.
Publicado: (2021)

Synthetic Thyroid Hormone Receptor-β Agonists Promote Oligodendrocyte Precursor Cell Differentiation in the Presence of Inflammatory Challenges
por: Baldassarro, Vito Antonio, et al.
Publicado: (2023)

TG68, a Novel Thyroid Hormone Receptor-β Agonist for the Treatment of NAFLD
por: Caddeo, Andrea, et al.
Publicado: (2021)

Endogenous 3-Iodothyronamine (T1AM) and Synthetic Thyronamine-Like Analog SG-2 Act as Novel Pleiotropic Neuroprotective Agents through the Modulation of SIRT6
por: Bellusci, Lorenza, et al.
Publicado: (2020)

Diphenyl-Methane Based Thyromimetic Inhibitors for Transthyretin Amyloidosis
por: Kim, Bokyung, et al.
Publicado: (2021)

New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection
por: Bellusci, Lorenza, et al.
Publicado: (2017)

Editorial: Calcium Metabolism: Hormonal Crosstalk, Pathophysiology and Disease
por: Battafarano, Giulia, et al.
Publicado: (2022)

Identification of a Thyroid Hormone Derivative as a Pleiotropic Agent for the Treatment of Alzheimer’s Disease
por: Runfola, Massimiliano, et al.
Publicado: (2021)

Memantine prodrug as a new agent for Alzheimer’s Disease
por: Sestito, Simona, et al.
Publicado: (2019)

Design, Synthesis, and In Vitro Evaluation of Novel 8-Amino-Quinoline Combined with Natural Antioxidant Acids
por: Bacci, Andrea, et al.
Publicado: (2022)

ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
por: Saponaro, Federica, et al.
Publicado: (2020)

3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome?
por: Rutigliano, Grazia, et al.
Publicado: (2020)

Editorial: Thyroid Hormone and Metabolites: Central Versus Peripheral Effects
por: Chiellini, Grazia, et al.
Publicado: (2019)

A clinician’s guide to understanding resistance to thyroid hormone due to receptor mutations in the TRα and TRβ isoforms
por: Singh, Brijesh K., et al.
Publicado: (2017)

Editorial: Thyroid hormone and metabolites: central versus peripheral effects, volume II
por: de Lange, Pieter, et al.
Publicado: (2023)

Hydrogen Sulfide: A Worthwhile Tool in the Design of New Multitarget Drugs
por: Sestito, Simona, et al.
Publicado: (2017)

Transthyretin Stabilization: An Emerging Strategy for the Treatment of Alzheimer’s Disease?
por: Saponaro, Federica, et al.
Publicado: (2020)

The Role of Cannabinoids in Bone Metabolism: A New Perspective for Bone Disorders
por: Saponaro, Federica, et al.
Publicado: (2021)

Comparative Analysis of Zearalenone Effects on Thyroid Receptor Alpha (TRα) and Beta (TRβ) Expression in Rat Primary Cerebellar Cell Cultures
por: Kiss, David Sandor, et al.
Publicado: (2018)

The Beta Agonist Lung Injury TrIal (BALTI) - prevention trial protocol
por: Perkins, Gavin D, et al.
Publicado: (2011)

Thyroid hormone dependent transcriptional programming by TRβ requires SWI/SNF chromatin remodelers
por: Gillis, Noelle E, et al.
Publicado: (2022)

T1AM/TAAR1 System Reduces Inflammatory Response and β-Amyloid Toxicity in Human Microglial HMC3 Cell Line
por: Polini, Beatrice, et al.
Publicado: (2023)

Biphasic expression of thyroid hormone receptor TRβ1 in mammalian retina and anterior ocular tissues
por: Ng, Lily, et al.
Publicado: (2023)

Dual PDK1/Aurora Kinase A Inhibitors Reduce Pancreatic Cancer Cell Proliferation and Colony Formation
por: Casari, Ilaria, et al.
Publicado: (2019)

Lipolytic Effects of 3-Iodothyronamine (T1AM) and a Novel Thyronamine-Like Analog SG-2 through the AMPK Pathway
por: Rogowski, Michael, et al.
Publicado: (2019)

Resistance to Thyroid Hormone Complicated with Type 2 Diabetes and Cardiomyopathy in a Patient with a TRβ Mutation
por: Wakasaki, Hisao, et al.
Publicado: (2016)

Synthesis and Functional Evaluation of Novel Aldose Reductase Inhibitors Bearing a Spirobenzopyran Scaffold
por: Digiacomo, Maria, et al.
Publicado: (2017)

TRα2—An Untuned Second Fiddle or Fine-Tuning Thyroid Hormone Action?
por: Hönes, Georg Sebastian, et al.
Publicado: (2022)

Cytoplasmic Localization of Thyroid Hormone Receptor (TR) Alpha and Nuclear Expression of Its Isoform TRα2 Determine Survival in Breast Cancer in Opposite Ways
por: Schneider, Mariella, et al.
Publicado: (2023)

Epibatidine: A Promising Natural Alkaloid in Health
por: Salehi, Bahare, et al.
Publicado: (2018)

Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells
por: Daniele, Simona, et al.
Publicado: (2015)

New Case of Thyroid Hormone Resistance α Caused by a Mutation of THRA/TRα1
por: Sun, Hui, et al.
Publicado: (2019)

Regulation of the THRA gene, encoding the thyroid hormone nuclear receptor TRα1, in intestinal lesions
por: Giolito, Maria Virginia, et al.
Publicado: (2022)

Thyroid hormone receptor (TR) mutants implicated in human hepatocellular carcinoma display an altered target gene repertoire
por: Chan, Ivan H., et al.
Publicado: (2009)

Characterization of skeletal phenotypes of TRα1(PV) and TRβ(PV) mutant mice: implications for tissue thyroid status and T3 target gene expression
por: O'Shea, Patrick J., et al.
Publicado: (2006)

Thyroid Hormone Receptor Agonist Promotes Hair Growth in Mice
por: Zhu, Peiqiu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uof7ru4g4h801nrqnp0lcdkn3h